FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Klaus Bendtzen

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Co-author Network

Publications

TOP 3
Signe Larsen; Klaus Bendtzen; Ole Haagen Nielsen
[Extraintestinal manifestations in inflammatory bowel disease].
Chris J Hedegaard; Ning Chen; Finn Sellebjerg; Per Soelberg Sørensen; Robert Graham Quinton Leslie; Klaus Bendtzen; Claus Henrik Nielsen
Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP.
Christian Enevold; Annette Bang Oturai; Per Soelberg Sørensen; lars peter ryder; Nils Koch-Henriksen; Klaus Bendtzen
Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Klaus Bendtzen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Signe Larsen; Klaus Bendtzen; Ole Haagen Nielsen
[Extraintestinal manifestations in inflammatory bowel disease].
Ugeskrift for laeger 2009;171(43):3078-83.
2009: Chris J Hedegaard; Ning Chen; Finn Sellebjerg; Per Soelberg Sørensen; Robert Graham Quinton Leslie; Klaus Bendtzen; Claus Henrik Nielsen
Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP.
Immunology 2009;128(1 Suppl):e451-61.
2009: Christian Enevold; Annette Bang Oturai; Per Soelberg Sørensen; lars peter ryder; Nils Koch-Henriksen; Klaus Bendtzen
Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1.
Journal of neuroimmunology 2009;212(1-2):125-31.
2009: Tanja Skuldbøl Borch; Morten Løbner; Klaus Bendtzen; Palle Holmstrup; Claus Henrik Nielsen
Decreased interleukin-2 responses to Fusobacterium nucleatum and Porphyromonas gingivalis in generalized aggressive periodontitis.
Journal of periodontology 2009;80(5):800-7.
2009: Lars K Sørensen; Anne Havemose-Poulsen; Klaus Bendtzen; Palle Holmstrup
Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
Journal of periodontology 2009;80(2):282-9.
2008: Karen Geismar; Christian Enevold; Lars Korsbaek Sørensen; Finn Gyntelberg; Klaus Bendtzen; Bjarne Sigurd; Palle Holmstrup
Involvement of interleukin-1 genotypes in the association of coronary heart disease with periodontitis.
Journal of periodontology 2008;79(12):2322-30.
2008: Katia Mangano; N Y Sardesai; cinzia quattrocchi; Emanuela Mazzon; Salvatore Cuzzocrea; Klaus Bendtzen; Pier Luigi Meroni; J J Kim; Ferdinando Nicoletti
Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats.
British journal of pharmacology 2008;155(5):722-30.
2008: Chris J Hedegaard; Martin Krakauer; Klaus Bendtzen; Per Soelberg Sørensen; Finn Sellebjerg; Claus H Nielsen
The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
Clinical immunology (Orlando, Fla.) 2008;129(1):80-9.
2008: Chris J Hedegaard; Martin Krakauer; Klaus Bendtzen; Henrik Lund; Finn Sellebjerg; Claus Henrik Nielsen
T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis.
Immunology 2008;125(2):161-9.
2008: P S Sorensen; Nils Koch-Henriksen; E M Flachs; Klaus Bendtzen
Is the treatment effect of IFN-beta restored after the disappearance of neutralizing antibodies?
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(6):837-42.
2008: Lone Skov; Laszlo Hegedüs; Sten Madsbad; Klaus Bendtzen
[New biological drugs for the treatment of chronic inflammatory diseases].
Ugeskrift for laeger 2008;170(24):2162.
2008: Bo Baslund; Klaus Bendtzen
[Biopharmaceuticals in the treatment of rheumatoid arthritis].
Ugeskrift for laeger 2008;170(24):2108-10.
2008: Lone Skov; Klaus Bendtzen
[Biological response modifiers in the treatment of immunoinflammatory diseases].
Ugeskrift for laeger 2008;170(24):2120-6.
2008: Klaus Bendtzen
[The immune system and inflammatory diseases].
Ugeskrift for laeger 2008;170(24):2110-5.
2008: Ole Haagen Nielsen; Klaus Bendtzen
[Biological drugs in the treatment of immunoinflammatory diseases].
Ugeskrift for laeger 2008;170(24):2103.
2008: Morten Løbner; Anette Walsted; Rune Larsen; Klaus Bendtzen; Claus Henrik Nielsen
Enhancement of human adaptive immune responses by administration of a high-molecular-weight polysaccharide extract from the cyanobacterium Arthrospira platensis.
Journal of medicinal food 2008;11(2):313-22.
2008: Katia Mangano; Niranjan Sardesai; Maria Antonia D'Alcamo; Massimo Libra; Lucia Malaguarnera; Marco Donia; Klaus Bendtzen; Pierluigi Meroni; Ferdinando Nicoletti
In vitro inhibition of enterobacteria-reactive CD4+CD25- T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027.
European journal of pharmacology 2008;586(1-3):313-21.
2008: Katia Mangano; Gabriele Dati; cinzia quattrocchi; Lidia Proietti; Clorinda Mazzarino; Roberto Di Marco; Klaus Bendtzen; Beatrice Greco; paola francesca zaratin; Ferdinando Nicoletti
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barrè syndrome.
Journal of neuroimmunology 2008;196(1-2):107-15.
2008: Mark A Ainsworth; Klaus Bendtzen; Jørn Brynskov
Tumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease.
The American journal of gastroenterology 2008;103(4):944-8.
2008: Lars K Sørensen; Anne Havemose-Poulsen; Søren U Sønder; Klaus Bendtzen; Palle Holmstrup
Blood cell gene expression profiling in subjects with aggressive periodontitis and chronic arthritis.
Journal of periodontology 2008;79(3):477-85.
2008: Rachel Farrell; Klaus Bendtzen; Antonio Bertolotto; Berwyn Clark; Manuel Comabella; Florian Deisenhammer; Anna Fogdell-Hahn; Gavin Giovannoni; Hans Peter Hartung; Bernard Hemmer; Jan Hillert; Ludwig Kappos; Joep Killestein; Raija Lindberg; Xavier Montalban; Chris Polman; Per Soelberg Sorensen
Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.
The Journal of international medical research 2008;36(1):204-8; author reply 208-10.
2007: Pia Galle; Lene Jensen; Christina Andersson; Salvatore Cuzzocrea; Rosanna Di Paola; Ferdinando Nicoletti; Morten Svenson; Klaus Bendtzen; Allan Randrup Thomsen; Morten B Hansen
Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation.
International immunopharmacology 2007;7(13):1704-13.
2007: Morten Svenson; Pierre Geborek; Tore Saxne; Klaus Bendtzen
Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies.
Rheumatology (Oxford, England) 2007;46(12):1828-34.
2007: Claus Henrik Nielsen; Daniel El Fassi; Hans Carl Hasselbalch; Klaus Bendtzen; Laszlo Hegedüs
B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.
Expert opinion on biological therapy 2007;7(7):1061-78.
2007: Per Soelberg Sorensen; Nils Koch-Henriksen; Klaus Bendtzen
Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(5):616-21.
2007: Klaus Bendtzen; Morten Svenson; Morten B Hansen
GM-CSF autoantibodies in pulmonary alveolar proteinosis.
The New England journal of medicine 2007;356(19):2001; author reply 2002.
2007: Lone Frier Bovin; Jørn Brynskov; Laszlo Hegedüs; Tine Jess; Claus Henrik Nielsen; Klaus Bendtzen
Gene expression profiling in autoimmune diseases: chronic inflammation or disease specific patterns?
Autoimmunity 2007;40(3):191-201.
2007: Claus Henrik Nielsen; L Albertsen; Klaus Bendtzen; B Baslund
Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells.
Clinical and experimental immunology 2007;148(2):288-95.
2007: Anne Havemose-Poulsen; Lars Korsbaek Sørensen; Klaus Bendtzen; Palle Holmstrup
Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis.
Journal of periodontology 2007;78(3):475-92.
2007: Claus Henrik Nielsen; Laszlo Hegedüs; Klaus Rieneck; A C Moeller; Robert Graham Quinton Leslie; Klaus Bendtzen
Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease.
Clinical and experimental immunology 2007;147(2):287-95.
2007: Klaus Bendtzen; Pierre Geborek; Morten Svenson; Lotta Larsson; Meliha C Kapetanovic; Tore Saxne
[Treatment of rheumatoid arthritis (RA) with anti-TNF-alpha antibody (Remicade). Individual monitoring of bioavailability and immunogenicity--secondary publication].
Ugeskrift for laeger 2007;169(5):420-3.
2006: Klaus Bendtzen; Pierre Geborek; Morten Svenson; Lotta Larsson; Meliha C Kapetanovic; Tore Saxne
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Arthritis and rheumatism 2006;54(12):3782-9.
2006: Søren Ulrik Salling Sønder; Anders Woetmann; Niels Odum; Klaus Bendtzen
Spironolactone induces apoptosis and inhibits NF-kappaB independent of the mineralocorticoid receptor.
Apoptosis : an international journal on programmed cell death 2006;11(12):2159-65.
2006: Daniel El Fassi; Claus Henrik Nielsen; Klaus Bendtzen
[Rituximab (MabThera) as treatment of active rheumatoid arthritis].
Ugeskrift for laeger 2006;168(47):4079-81.
2006: Per Soelberg Sorensen; Thomas Tscherning; Henrik Kahr Mathiesen; Annika Reynberg Langkilde; Christian Ross; Mads Ravnborg; Klaus Bendtzen
Neutralizing antibodies hamper IFNbeta bioactivity and treatment effect on MRI in patients with MS.
Neurology 2006;67(9):1681-3.
2006: Lone Forner; Claus Henrik Nielsen; Klaus Bendtzen; Tove Larsen; Palle Holmstrup
Increased plasma levels of IL-6 in bacteremic periodontis patients after scaling.
Journal of clinical periodontology 2006;33(10):724-9.
2006: Bodil Petersen; Klaus Bendtzen; Nils Koch-Henriksen; Mads Ravnborg; Christian Ross; Per Soelberg Sorensen
Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(3):247-52.
2006: Søren Ulrik Salling Sønder; Marianne Mikkelsen; Klaus Rieneck; Chris Juul Hedegaard; Klaus Bendtzen
Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction.
British journal of pharmacology 2006;148(1):46-53.
2006: M Mikkelsen; Søren Ulrik Salling Sønder; Jacob Nersting; Klaus Bendtzen
Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression.
Apoptosis : an international journal on programmed cell death 2006;11(4):573-9.
2006: Claus Henrik Nielsen; Ane Christine Moeller; Laszlo Hegedüs; Klaus Bendtzen; Robert Graham Quinton Leslie
Self-reactive CD4+ T cells and B cells in the blood in health and autoimmune disease: increased frequency of thyroglobulin-reactive cells in Graves' disease.
Journal of clinical immunology 2006;26(2):126-37.
2006: Anne Havemose-Poulsen; Jytte Westergaard; Kaj Stoltze; Henrik Skjødt; Bente Danneskiold-Samsøe; Henning Locht; Klaus Bendtzen; Palle Holmstrup
Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis.
Journal of periodontology 2006;77(2):280-8.
2006: Christian Ross; Katja Maria Clemmesen; Per Soelberg Sørensen; Nils Koch-Henriksen; Klaus Bendtzen
Measuring and evaluating interferon beta-induced antibodies in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(1):39-46.
2005: Anne Havemose-Poulsen; Lars Korsbaek Sørensen; Kaj Stoltze; Klaus Bendtzen; Palle Holmstrup
Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis.
Journal of periodontology 2005;76(12):2276-85.
2005: Per Soelberg Sorensen; Nils Koch-Henriksen; Christian Ross; Katja Maria Clemmesen; Klaus Bendtzen
Appearance and disappearance of neutralizing antibodies during interferon-beta therapy.
Neurology 2005;65(1):33-9.
2005: M C B Grauballe; Bo Hjorth Bentzen; Magnús Jón Björnsson; Dennis Moe; Thomas E N Jonassen; Klaus Bendtzen; Kaj Stoltze; Palle Holmstrup
The effect of spironolactone on experimental periodontitis in rats.
Journal of periodontal research 2005;40(3):212-7.
2005: Birgitte Bjørnhart; Pernille Svenningsen; Sif Gudbrandsdottir; Marek Zak; Susan Nielsen; Klaus Bendtzen; Klaus Müller
Plasma TNF binding capacity in patients with juvenile idiopathic arthritis.
International immunopharmacology 2005;5(1):73-7.
2005: Johnny Andersen; Carsten Heilmann; Niels Jacobsen; Klaus Bendtzen; Klaus Müller
Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation.
International immunopharmacology 2005;5(1):67-71.
2004: Pia Galle; Morten Svenson; Klaus Bendtzen; Morten B Hansen
High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors.
European journal of immunology 2004;34(11):3267-75.
2004: Steen Sørensen; Nils Koch-Henriksen; Christian Ross Pedersen; Katja Maria Clemmesen; Klaus Bendtzen; Jette Lautrup Frederiksen; Kai Jensen; Ole Kristensen; Thor Petersen; Søren Rasmussen; Mads Ravnborg; Egon Stenager
[Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis].
Ugeskrift for laeger 2004;166(41):3606-9.
2004: Rosanna Di Paola; Roberto Di Marco; Emanuela Mazzon; Tiziana Genovese; Klaus Bendtzen; Battesimo Macrì; Ferdinando Nicoletti; Salvatore Cuzzocrea
Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody.
Clinical immunology (Orlando, Fla.) 2004;113(1):64-73.
2004: Klaus Bendtzen; Peter Riis Hansen; Klaus Rieneck
[Spironolactone inhibits production of proinflammatory cytokines, including tumor necrosis factor-alpha and interferon-gamma and has potential effect in the treatment of arthritis].
Ugeskrift for laeger 2004;166(37):3203-7.
2004: Klaus Bendtzen
[Adalimumab in the treatment of rheumatoid arthritis].
Ugeskrift for laeger 2004;166(26-31):2552-4.
2004: Lone Frier Bovin; Klaus Rieneck; Christopher Workman; Henrik Nielsen; Søren Freiesleben Sørensen; Henrik Skjødt; Adrian Florescu; Søren Brunak; Klaus Bendtzen
Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor.
Immunology letters 2004;93(2-3):217-26.
2004: Klaus Bendtzen
Natural and therapy-induced antibodies to cytokines.
Drug discovery today 2004;9(6):259.
2004: Peter Riis Hansen; Klaus Rieneck; Klaus Bendtzen
Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells.
Immunology letters 2004;91(2-3):87-91.
2004: Sif Gudbrandsdottir; Henning Bliddal; A Petri; Lene Terslev; Bente Danneskiold-Samsoe; B Bjørnhart; Klaus Bendtzen; Klaus Müller
Plasma TNF binding capacity profiles during treatment with etanercept in rheumatoid arthritis.
Scandinavian journal of rheumatology 2004;33(6):385-8.
2004: Hanne Christensen; Helle Hjorth Johannesen; Anders F Christensen; Klaus Bendtzen; Gudrun Boysen
Serum cardiac troponin I in acute stroke is related to serum cortisol and TNF-alpha.
Cerebrovascular diseases (Basel, Switzerland) 2004;18(3):194-9.
2004: Sif Gudbrandsdottir; R Larsen; L K Sørensen; Susan Nielsen; Morten B Hansen; Morten Svenson; Klaus Bendtzen; Klaus Müller
TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis.
Clinical and experimental rheumatology 2004;22(1):118-24.
2004: Pia Galle; Lotte Hougs; Torben Barington; Morten Svenson; Arne Svejgaard; Allan Randrup Thomsen; Klaus Bendtzen; Morten B Hansen
Knocking out IL-6 by vaccination.
European journal of immunology 2004;34(1):291-300.
2003: Roberto Di Marco; Katia Mangano; cinzia quattrocchi; Rosario Musumeci; Annamaria Speciale; Gianpaolo Papaccio; Karsten Buschard; Klaus Bendtzen; Ferdinando Nicoletti
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats.
Clinical immunology (Orlando, Fla.) 2003;109(3):266-71.
2003: Klaus Bendtzen
[Immunogenicity of biopharmaceuticals. Experiences with beta-interferon, EPO and anti-TNF].
Ugeskrift for laeger 2003;165(48):4629-32.
2003: Klaus Bendtzen
[Problems with clinical use of recombinant proteins].
Ugeskrift for laeger 2003;165(48):4625.
2003: Per Soelberg Sorensen; Christian Ross; Katja Maria Clemmesen; Klaus Bendtzen; Jette Lautrup Frederiksen; Kai Jensen; Ole Kristensen; Thor Petersen; Søren Rasmussen; Mads Ravnborg; Egon Stenager; Nils Koch-Henriksen
Antibodies to IFN-beta: the Danish National IFN-beta Project.
Neurology 2003;61(9 Suppl 5):S27-8.
2003: Klaus Bendtzen
Anti-IFN BAb and NAb antibodies: a minireview.
Neurology 2003;61(9 Suppl 5):S6-10.
2003: Per Soelberg Sorensen; Christian Ross; Katja Maria Clemmesen; Klaus Bendtzen; Jette Lautrup Frederiksen; Kai Jensen; Ole Kristensen; Thor Petersen; Søren Rasmussen; Mads Ravnborg; Egon Stenager; Nils Koch-Henriksen
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis.
Lancet 2003;362(9391):1184-91.
2003: Jacob Nersting; Morten Svenson; Vagn Andersen; Klaus Bendtzen
Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor alpha.
Immunology letters 2003;89(1):59-65.
2003: Klaus Bendtzen; Peter Riis Hansen; Klaus Rieneck
Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis.
Clinical and experimental immunology 2003;134(1):151-8.
2003: Ferdinando Nicoletti; Roberto Di Marco; Gianpaolo Papaccio; Ignacio Conget; Ramon Gomis; Renato Bernardini; John E Sims; Yehuda Shoenfeld; Klaus Bendtzen
Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct.
European journal of immunology 2003;33(8):2278-86.
2003: Sven Arvid Birkeland; SJ Hamilton-Dutoit; Klaus Bendtzen
Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.
Transplantation 2003;76(1):153-8.
2003: Tetsushi Kaneko; Masahiro Itoh; Yoichi Nakamura; Akira Iimura; Shogo Hayashi; Kodo Takahashi; Franca Stivala; Klaus Bendtzen; Ferdinando Nicoletti
Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis.
Cytokine 2003;22(1-2):50-3.
2003: Morten Svenson; Henrik H Jacobi; Uffe Bødtger; Lars K Poulsen; Klaus Rieneck; Klaus Bendtzen
Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1.
Molecular immunology 2003;39(10):603-12.
2002: Søren L Petersen; Charlotte Astrid Russell; Klaus Bendtzen; Lars L Vindeløv
Optimisation of the CT h4S bioassay for detection of human interleukin-4 secreted by mononuclear cells stimulated by phytohaemaglutinin or by human leukocyte antigen mismatched mixed lymphocyte culture.
Immunology letters 2002;84(1):29-39.
2002: Hanne Christensen; Gudrun Boysen; Helle Hjorth Johannesen; Erik Christensen; Klaus Bendtzen
Deteriorating ischaemic stroke. cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke.
Journal of the neurological sciences 2002;201(1-2):1-7.
2002: Jacob Nersting; Vagn Andersen; Klaus Bendtzen
[Autoinflammatory disease: a new concept].
Ugeskrift for laeger 2002;164(37):4269-71.
2002: Gianpaolo Papaccio; Ferdinando Nicoletti; Francesco Aurelio Pisanti; Michela Galdieri; Klaus Bendtzen
An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells.
Molecular medicine (Cambridge, Mass.) 2002;8(9):536-45.
2002: Ferdinando Nicoletti; Ignacio Conget; M Di Mauro; Roberto Di Marco; Maria Clorinda Mazzarino; Klaus Bendtzen; A Messina; R Gomis
Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease.
Diabetologia 2002;45(8):1107-10.
2002: Niels Graudal; M Svenson; Ulrik Tarp; Peter Garred; Anne Grethe Jurik; Klaus Bendtzen
Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome.
Annals of the rheumatic diseases 2002;61(7):598-602.
2002: Christian Ross; Claus Bødker Engler; Birgit Sander; Klaus Bendtzen
IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-alpha2a.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(4):421-6.
2002: Hanne Christensen; Gudrun Boysen; Erik Christensen; Helle Hjorth Johannesen; Klaus Bendtzen
Plasma cytokines in acute stroke.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2002;11(2):72-9.
2002: Lu Li; Masahiro Itoh; Maila Ablake; Battesimo Macrì; Klaus Bendtzen; Ferdinando Nicoletti
Prevention of murine experimental autoimmune orchitis by recombinant human interleukin-6.
Clinical immunology (Orlando, Fla.) 2002;102(2):135-7.
2001: O Jónasdóttir; Jørgen Petersen; Klaus Bendtzen
Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2001;109(11):781-6.
2001: Klaus Bendtzen; Lone Frier Bovin; Vagn Andersen; Klaus Rieneck; Morten Svenson
[Toll-like receptors. What can we learn about the immune system from banana flies and a mouse strain].
Ugeskrift for laeger 2001;163(34):4562-5.
2001: Ferdinando Nicoletti; Roberto Di Marco; Katia Mangano; Francesco Patti; Ester Reggio; Alessandra Nicoletti; Klaus Bendtzen; Arturo Reggio
Increased serum levels of interleukin-18 in patients with multiple sclerosis.
Neurology 2001;57(2):342-4.
2001: Ferdinando Nicoletti; Roberto Di Marco; Paola Sacerdote; Pierluigi Meroni; Katia Mangano; C Edwards; A Bartorelli; Klaus Bendtzen; Alberto E Panerai
Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14.
Antimicrobial agents and chemotherapy 2001;45(5):1591-4.
2001: Roberto Di Marco; G Puglisi; Gianpaolo Papaccio; Alessandra Nicoletti; Francesco Patti; Arturo Reggio; Klaus Bendtzen; Ferdinando Nicoletti
Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(2):101-4.
2001: Ferdinando Nicoletti; Ignacio Conget; Roberto Di Marco; Annamaria Speciale; R Morìnigo; Klaus Bendtzen; R Gomis
Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes.
Diabetologia 2001;44(3):309-11.
2000: Klaus Rieneck; Lone Frier Bovin; Knud Josefsen; Karsten Buschard; Morten Svenson; Klaus Bendtzen
Massive parallel gene expression profiling of RINm5F pancreatic islet beta-cells stimulated with interleukin-1beta.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2000;108(12):855-72.
2000: Gitte Pedersen; T Saermark; Klaus Bendtzen; Jørn Brynskov
Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFNgamma, TNFalpha and IL-1beta on viability, butyrate oxidation and IL-8 secretion.
Autoimmunity 2000;32(4):255-63.
2000: Ferdinando Nicoletti; Roberto Di Marco; Ignacio Conget; R Gomis; C Edwards; Gianpaolo Papaccio; Klaus Bendtzen; S Sandler
Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin.
Journal of autoimmunity 2000;15(4):395-405.
2000: Christian Ross; Katja Maria Clemmesen; Morten Svenson; Per Soelberg Sørensen; Nils Koch-Henriksen; G L Skovgaard; Klaus Bendtzen
Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group.
Annals of neurology 2000;48(5):706-12.
2000: Ferdinando Nicoletti; Roberto Di Marco; Paola Zaccone; A Salvaggio; G Magro; Klaus Bendtzen; Pierluigi Meroni
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism.
Hepatology (Baltimore, Md.) 2000;32(4 Pt 1):728-33.
2000: Gitte Pedersen; T Saermark; T Horn; B Giese; Klaus Bendtzen; Jørn Brynskov
Cytokine-induced impairment of short-chain fatty acid oxidation and viability in human colonic epithelial cells.
Cytokine 2000;12(9):1400-4.
2000: Gianpaolo Papaccio; Ferdinando Nicoletti; Francesco Aurelio Pisanti; Klaus Bendtzen; Michela Galdieri
Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells.
Endocrinology 2000;141(4):1500-5.
2000: Morten Svenson; Morten B Hansen; Allan Randrup Thomsen; M Diamant; Anneline Nansen; Klaus Rieneck; I G Otterness; Klaus Bendtzen
Cytokine vaccination: neutralising IL-1alpha autoantibodies induced by immunisation with homologous IL-1alpha.
Journal of immunological methods 2000;236(1-2):1-8.
2000: Klaus Bendtzen; Morten B Hansen; Christian Ross; Morten Svenson
Detection of autoantibodies to cytokines.
Molecular biotechnology 2000;14(3):251-61.
2000: C N Meyer; Morten Svenson; C Schade Larsen; N Odum; Peter Skinhøj; Klaus Bendtzen
Low prevalence of antibodies and other plasma factors binding to CC chemokines and IL-2 in HIV-positive patients.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2000;108(2):122-30.
2000: L S Andersen; Jørgen Petersen; Klaus Bendtzen
Production of interleukin (IL)-1beta, IL-1 receptor antagonist and IL-10 by blood mononuclear cells in chronic arthritis.
Cytokine 2000;12(1):62-8.
1999: Henrik Nielsen; AA Petersen; Henrik Skjødt; Kim Hørslev-Petersen; Klaus Bendtzen
Blood levels of CD11b+ memory T lymphocytes are selectively upregulated in patients with active rheumatoid arthritis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1999;107(12):1124-30.
1999: Ferdinando Nicoletti; Paola Zaccone; Ignacio Conget; R Gomis; C Möller; Pier Luigi Meroni; Klaus Bendtzen; W Trepicchio; S Sandler
Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice.
Diabetes 1999;48(12):2333-9.
1999: Lone Frier Bovin; Klaus Bendtzen
[Apoptosis--programmed cell death].
Ugeskrift for laeger 1999;161(42):5778-82.
1999: Paola Zaccone; J Phillips; Ignacio Conget; R Gomis; K Haskins; A Minty; Klaus Bendtzen; A Cooke; Ferdinando Nicoletti
Interleukin-13 prevents autoimmune diabetes in NOD mice.
Diabetes 1999;48(8):1522-8.
1999: Lone Frier Bovin; Pam Fredman; Jan-Eric Månsson; Karsten Buschard; Klaus Bendtzen
In vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide.
FEBS letters 1999;455(3):339-43.
1999: Keld Ostergaard; CB Andersen; Jørgen Petersen; Klaus Bendtzen; DM Salter
Validity of histopathological grading of articular cartilage from osteoarthritic knee joints.
Annals of the rheumatic diseases 1999;58(4):208-13.
1999: E Strandell; Anne Kaas; Marie-Louise Hartoft-Nielsen; T Bock; Karsten Buschard; Klaus Bendtzen
Cytokine production in NOD mice on prophylactic insulin therapy.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1999;107(4):413-9.
1999: Sven Arvid Birkeland; Klaus Bendtzen; Bjarne Møller; SJ Hamilton-Dutoit; HK Andersen
Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation.
Transplantation 1999;67(6):876-81.
1999: L S Andersen; Jørgen Petersen; Morten Svenson; Klaus Bendtzen
Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE.
Autoimmunity 1999;30(4):235-42.
1998: Aldo E Calogero; Ferdinando Nicoletti; Marco A Palumbo; Nunziatina Burrello; Maria Gaetana Di Mauro; M Lunetta; Klaus Bendtzen; Antonio Cianci
Macrophage-derived cytokines in the follicular fluids of women with infertility due to immunological causes. Elevated levels of interleukin 6 and low levels of granulocyte-macrophage colony-stimulating factor.
Cytokine 1998;10(10):814-8.
1998: Ferdinando Nicoletti; Alessandra Nicoletti; S Giuffrida; Roberto Di Marco; Pierluigi Meroni; Klaus Bendtzen; M Lunetta
Sodium fusidate in Gillain-Barré syndrome: a case report.
Journal of neurology, neurosurgery, and psychiatry 1998;65(2):266-8.
1998: Keld Ostergaard; DM Salter; Jørgen Petersen; Klaus Bendtzen; J Hvolris; CB Andersen
Expression of alpha and beta subunits of the integrin superfamily in articular cartilage from macroscopically normal and osteoarthritic human femoral heads.
Annals of the rheumatic diseases 1998;57(5):303-8.
1998: Klaus Müller; E B Herner; A Stagg; Klaus Bendtzen; P Woo
Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis.
British journal of rheumatology 1998;37(5):562-9.
1998: Klaus Bendtzen; Morten B Hansen; Christian Ross; Morten Svenson
High-avidity autoantibodies to cytokines.
Immunology today 1998;19(5):209-11.
1998: Klaus Bendtzen
Autoantibodies to cytokines.
European journal of clinical investigation 1998;28(4):300-1.
1998: Morten Svenson; Morten B Hansen; Christian Ross; M Diamant; Klaus Rieneck; H Nielsen; Klaus Bendtzen
Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.
Blood 1998;91(6):2054-61.
1998: C U Henriques; G E Rice; M H Wong; Klaus Bendtzen
Immunolocalisation of interleukin-4 and interleukin-4 receptor in placenta and fetal membranes in association with pre-term labour and pre-eclampsia.
Gynecologic and obstetric investigation 1998;46(3):172-7.
1997: Ferdinando Nicoletti; B Beltrami; Elena Raschi; Roberto Di Marco; G Magro; S Grasso; Klaus Bendtzen; G Fiorelli; Pier Luigi Meroni
Protection from concanavalin A (Con A)-induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate.
Clinical and experimental immunology 1997;110(3):479-84.
1997: Keld Ostergaard; DM Salter; CB Andersen; Jørgen Petersen; Klaus Bendtzen
CD44 expression is up-regulated in the deep zone of osteoarthritic cartilage from human femoral heads.
Histopathology 1997;31(5):451-9.
1997: Keld Ostergaard; Jørgen Petersen; CB Andersen; Klaus Bendtzen; DM Salter
Histologic/histochemical grading system for osteoarthritic articular cartilage: reproducibility and validity.
Arthritis and rheumatism 1997;40(10):1766-71.
1997: Laura Ciapponi; Domenico Maione; A Scoumanne; Patrizia Costa; Morten B Hansen; Morten Svenson; Klaus Bendtzen; Tonino Alonzi; Giacomo Paonessa; Riccardo Cortese; Gennaro Ciliberto; Rocco Savino
Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist.
Nature biotechnology 1997;15(10):997-1001.
1997: Christian Ross; Morten Svenson; H Nielsen; C Lundsgaard; Morten B Hansen; Klaus Bendtzen
Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy.
Blood 1997;90(6):2376-80.
1997: G Pedersen; A M Dalseg; Jørn Brynskov; Klaus Bendtzen
[The role of cell adhesion molecules in inflammatory bowel disease and colorectal cancer].
Ugeskrift for laeger 1997;159(34):5077-84.
1997: Henrik Ullum; Alessandro Cozzi-Lepri; Klaus Bendtzen; J Victor; P C Gøtzsche; AN Phillips; Peter Skinhøj; Bente Klarlund Pedersen
Low production of interferon gamma is related to disease progression in HIV infection: evidence from a cohort of 347 HIV-infected individuals.
AIDS research and human retroviruses 1997;13(12):1039-46.
1997: M Diamant; Klaus Rieneck; N Mechti; X G Zhang; Morten Svenson; Klaus Bendtzen; B Klein
Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130.
FEBS letters 1997;412(2):379-84.
1997: Klaus Müller; Marek Zak; Susan Nielsen; Freddy Karup Pedersen; P de Nully; Klaus Bendtzen
Interleukin-1 receptor antagonist in neonates, children and adults, and in patients with pauci- and polyarticular onset juvenile chronic arthritis.
Clinical and experimental rheumatology 1997;15(4):439-44.
1997: Ferdinando Nicoletti; Giuseppe Mancuso; Valentina Valeria Cusumano; Roberto Di Marco; Paola Zaccone; Klaus Bendtzen; Giuseppe Teti
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13.
European journal of immunology 1997;27(6):1580-3.
1997: Henrik Ullum; J Victor; Terese L Katzenstein; Jan Gerstoft; P C Gøtzsche; Klaus Bendtzen; Peter Skinhøj; Bente Klarlund Pedersen
Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjects.
The Journal of infectious diseases 1997;175(6):1507-10.
1997: PH Jakobsen; Claus Koch; Klaus Bendtzen
Inhibition of LPS and Plasmodium falciparum induced cytokine secretion by pentoxifylline and two analogues.
Scandinavian journal of immunology 1997;45(5):546-50.
1997: Klaus Bendtzen; Ulla Feldt-Rasmussen
[Chemokines and HIV infection].
Ugeskrift for laeger 1997;159(13):1956-7.
1997: Bo Abrahamsen; Klaus Bendtzen; Henning Beck-Nielsen
Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra.
Bone 1997;20(3):251-8.
1997: Klaus Rieneck; J Renneberg; M Diamant; E Gutschik; Klaus Bendtzen
Molecular cloning and expression of a novel Staphylococcus aureus antigen.
Biochimica et biophysica acta 1997;1350(2):128-32.
1997: Ib C Bygbjerg; M B Hansen; Anita M Rønn; Klaus Bendtzen; PH Jakobsen
Decreased plasma levels of factor II + VII + X correlate with increased levels of soluble cytokine receptors in patients with malaria and meningococcal infections.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1997;105(2):150-6.
1997: KH Asmussen; Vagn Andersen; G Bendixen; Klaus Bendtzen; Jan Ulrik Prause; Jens Thorn; Allan Wiik; P Oxholm
Quantitative assessment of clinical disease status in primary Sjögren's syndrome. A cross-sectional study using a new classification model.
Scandinavian journal of rheumatology 1997;26(3):197-205.
1996: Karsten Buschard; M Diamant; L E Bovin; J E Månsson; P Fredman; Klaus Bendtzen
Sulphatide and its precursor galactosylceramide influence the production of cytokines in human mononuclear cells.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1996;104(12):938-44.
1996: C Homann; M B Hansen; Niels Graudal; P Hasselqvist; M Svenson; Klaus Bendtzen; A C Thomsen; Peter Garred
Anti-interleukin-6 autoantibodies in plasma are associated with an increased frequency of infections and increased mortality of patients with alcoholic cirrhosis.
Scandinavian journal of immunology 1996;44(6):623-9.
1996: Henrik Ullum; M Diamant; J Victor; P C Gøtzsche; Klaus Bendtzen; P Skinhøj; Bente Klarlund Pedersen
Increased circulating levels of interleukin-6 in HIV-seropositive subjects.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;13(1):93-4.
1996: K Müller; Marek Zak; Susan Nielsen; Freddy Karup Pedersen; P de Nully; Klaus Bendtzen
In vitro cytokine production and phenotype expression by blood mononuclear cells from umbilical cords, children and adults.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 1996;7(3):117-24.
1996: PH Jakobsen; V McKay; R N'Jie; BO Olaleye; Umberto D'Alessandro; Klaus Bendtzen; Inger Schousboe; Brian M Greenwood
Soluble products of inflammatory reactions are not induced in children with asymptomatic Plasmodium falciparum infections.
Clinical and experimental immunology 1996;105(1):69-73.
1996: M Diamant; Morten B Hansen; Klaus Rieneck; Morten Svenson; K Yasukawa; Klaus Bendtzen
Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors.
Leukemia research 1996;20(4):291-301.
1996: Ferdinando Nicoletti; P L Meroni; Klaus Bendtzen
Fusidic acid and insulin-dependent diabetes mellitus.
Autoimmunity 1996;24(3):187-97.
1996: K Müller; M B Hansen; Marek Zak; Susan Nielsen; Freddy Karup Pedersen; P de Nully; Klaus Bendtzen
Autoantibodies to IL-1 alpha in sera from umbilical cords, children, and adults, and from patients with juvenile chronic arthritis.
Scandinavian journal of rheumatology 1996;25(3):164-7.
1995: Klaus Bendtzen
[Molecular biology and inflammation].
Ugeskrift for laeger 1995;157(35):4799-802.
1995: Ferdinando Nicoletti; Paola Zaccone; Roberto Di Marco; G Magro; S Grasso; S Morrone; A Santoni; G Tempera; P L Meroni; Klaus Bendtzen
Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.
Immunology 1995;85(4):645-50.
1995: Morten B Hansen; M Svenson; M Diamant; Kathrine Abell; Klaus Bendtzen
Interleukin-6 autoantibodies: possible biological and clinical significance.
Leukemia 1995;9(7):1113-5.
1995: C Ross; M Svenson; M B Hansen; G L Vejlsgaard; Klaus Bendtzen
High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
The Journal of clinical investigation 1995;95(5):1974-8.
1995: Klaus Bendtzen; Morten B Hansen; Christian Ross; L K Poulsen; Morten Svenson
Cytokines and autoantibodies to cytokines.
Stem cells (Dayton, Ohio) 1995;13(3):206-22.
1995: G Bendixen; Klaus Bendtzen
[Molecular biology and rheumatology].
Ugeskrift for laeger 1995;157(17):2421-3.
1995: Knud Josefsen; H Nielsen; W A Hansen; J K Kristensen; T Bilde; Klaus Bendtzen; Karsten Buschard
Tissue culture supernatants from human islets of Langerhans activate the oxidative burst response of human monocytes in vitro.
Life sciences 1995;56(16):1333-42.
1995: Morten B Hansen; M Svenson; Kathrine Abell; K Yasukawa; M Diamant; Klaus Bendtzen
Influence of interleukin-6 (IL-6) autoantibodies on IL-6 binding to cellular receptors.
European journal of immunology 1995;25(2):348-54.
1995: L S Andersen; Jørgen Petersen; M Svenson; Klaus Bendtzen
IgG for intravenous use, autologous serum and plasma induce comparable interleukin-1 receptor antagonist liberation from human mononuclear cells: an in vitro phenomenon depending upon plastic adherence.
Autoimmunity 1995;22(2):127-33.
1995: A Rodgaard; B S Thomsen; G Bendixen; Klaus Bendtzen
Increased expression of complement receptor type 1 (CR1, CD35) on human peripheral blood T lymphocytes after polyclonal activation in vitro.
Immunologic research 1995;14(1):69-76.
1995: M B Hansen; Vagn Andersen; K Rohde; Adrian Florescu; C Ross; M Svenson; Klaus Bendtzen
Cytokine autoantibodies in rheumatoid arthritis.
Scandinavian journal of rheumatology 1995;24(4):197-203.
1994: M Kemp; A S Hey; Klaus Bendtzen; Arsalan Kharazmi; Thor G Theander
Th1-like human T-cell clones recognizing Leishmania gp63 inhibit Leishmania major in human macrophages.
Scandinavian journal of immunology 1994;40(6):629-35.
1994: Klaus Bendtzen
Cytokines and natural regulators of cytokines.
Immunology letters 1994;43(1-2):111-23.
1994: Ase Krogh Rasmussen; Henrik Nielsen; Vagn Andersen; Torben Barington; Klaus Bendtzen; Morten B Hansen; L Nielsen; Bente Klarlund Pedersen; Allan Wiik
[Chronic fatigue syndrome--a controlled cross-sectional study].
Ugeskrift for laeger 1994;156(46):6836-40.
1994: Ase Krogh Rasmussen; L Kayser; Ulla Feldt-Rasmussen; Klaus Bendtzen
Influence of tumour necrosis factor-alpha, tumour necrosis factor-beta and interferon-gamma, separately and added together with interleukin-1 beta, on the function of cultured human thyroid cells.
The Journal of endocrinology 1994;143(2):359-65.
1994: PH Jakobsen; V McKay; S D Morris-Jones; W McGuire; MB Van Hensbroek; S Meisner; Klaus Bendtzen; Inger Schousboe; Ib C Bygbjerg; Brian M Greenwood
Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria.
Infection and immunity 1994;62(10):4374-9.
1994: T Horn; Klaus Bendtzen; I Hageman; Karsten Buschard
Morphological effects of sodium fusidate (fusidin) on pancreatic islet cells: an electron microscopic study.
Pharmacology & toxicology 1994;75(3-4):228-30.
1994: M Diamant; Morten B Hansen; Klaus Rieneck; Morten Svenson; K Yasukawa; Klaus Bendtzen
Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors.
Journal of immunological methods 1994;173(2):229-35.
1994: Ase Krogh Rasmussen; Henrik Nielsen; Vagn Andersen; Torben Barington; Klaus Bendtzen; Morten B Hansen; L Nielsen; Bente Klarlund Pedersen; Allan Wiik
Chronic fatigue syndrome--a controlled cross sectional study.
The Journal of rheumatology 1994;21(8):1527-31.
1994: PH Jakobsen; S Morris-Jones; Thor G Theander; Lars Hviid; M B Hansen; Klaus Bendtzen; RG Ridley; Brian M Greenwood
Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria.
Clinical and experimental immunology 1994;96(1):98-103.
1994: M B Hansen; M Svenson; Kathrine Abell; Kim Varming; H P Nielsen; A Bertelsen; Klaus Bendtzen
Sex- and age-dependency of IgG auto-antibodies against IL-1 alpha in healthy humans.
European journal of clinical investigation 1994;24(3):212-8.
1994: Ferdinando Nicoletti; Roberto Di Marco; S Morrone; Paola Zaccone; David Lembo; S Grasso; A Santoni; P L Meroni; Klaus Bendtzen
Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma.
Immunology 1994;81(2):317-21.
1994: M Nielsen; Niels Odum; Klaus Bendtzen; lars peter ryder; B K Jakobsen; Arne Svejgaard
MHC class II molecules regulate growth in human T cells.
Experimental and clinical immunogenetics 1994;11(1):23-32.
1993: M Svenson; M B Hansen; Klaus Bendtzen
Binding of cytokines to pharmaceutically prepared human immunoglobulin.
The Journal of clinical investigation 1993;92(5):2533-9.
1993: M Kemp; Jørgen A L Kurtzhals; C B Christensen; Arsalan Kharazmi; Armando Jardim; Klaus Bendtzen; G S Gachihi; Robert W Olafson; Thor G Theander
Production of interferon-gamma and interleukin-4 by human T cells recognizing Leishmania lipophosphoglycan-associated protein.
Immunology letters 1993;38(2):137-44.
1993: A Andersen; H Pedersen; Klaus Bendtzen; Carsten Röpke
Effects of growth factors on cytokine production in serum-free cultures of human thymic epithelial cells.
Scandinavian journal of immunology 1993;38(3):233-8.
1993: M Svenson; Morten B Hansen; P Heegaard; Kathrine Abell; Klaus Bendtzen
Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.
Cytokine 1993;5(5):427-35.
1993: Klaus Rieneck; M Diamant; P M Haahr; M Schönharting; Klaus Bendtzen
In vitro immunomodulatory effects of pentoxifylline.
Immunology letters 1993;37(2-3):131-8.
1993: Gitte Kronborg; Morten B Hansen; M Svenson; A Fomsgaard; Niels Høiby; Klaus Bendtzen
Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.
Pediatric pulmonology 1993;15(5):292-7.
1993: M Kemp; Jørgen A L Kurtzhals; Klaus Bendtzen; L K Poulsen; M B Hansen; Davy K Koech; Arsalan Kharazmi; Thor G Theander
Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
Infection and immunity 1993;61(3):1069-73.
1993: K Müller; Niels Odum; Klaus Bendtzen
1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro.
Immunology letters 1993;35(2):177-82.
1993: Morten B Hansen; M Svenson; M Diamant; Klaus Bendtzen
High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro.
Cytokine 1993;5(1):72-80.
1992: K Müller; P M Haahr; M Diamant; Klaus Rieneck; A Kharazmi; Klaus Bendtzen
1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level.
Cytokine 1992;4(6):506-12.
1992: K Müller; Klaus Rieneck; Morten B Hansen; Klaus Bendtzen
1,25-Dihydroxyvitamin D3-mediated suppression of T lymphocyte functions and failure of T cell-activating cytokines to restore proliferation.
Immunology letters 1992;34(1):37-44.
1992: Ebbe Langholz; Jørn Brynskov; Klaus Bendtzen; M Vilien; Vibeke Binder
Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin.
Alimentary pharmacology & therapeutics 1992;6(4):495-502.
1992: T W Kjaer; J Rygaard; Klaus Bendtzen; Knud Josefsen; T Bock; Karsten Buschard
Interleukins increase surface ganglioside expression of pancreatic islet cells in vitro.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1992;100(6):509-14.
1992: M B Hansen; M Svenson; Klaus Bendtzen
Serum-induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN-alpha in normal human sera.
Clinical and experimental immunology 1992;88(3):559-62.
1992: Lisa D Christensen; Vagn Andersen; P Nygaard; Klaus Bendtzen
Effects of immunomodulators on ecto-5'-nucleotidase activity on blood mononuclear cells in vitro.
Scandinavian journal of immunology 1992;35(4):407-13.
1992: Klaus Bendtzen; M Diamant; T Horn; C Pedersen; Karsten Buschard
Effect of fusidic acid on interleukin-1 (IL-1)- and IL-6-induced pancreatic beta-cell functions in rats.
The Journal of endocrinology 1992;132(3):345-52.
1992: M Svenson; Morten B Hansen; L Kayser; Ase Krogh Rasmussen; Claus Reimert; Klaus Bendtzen
Effects of human anti-IL-1 alpha autoantibodies on receptor binding and biological activities of IL-1.
Cytokine 1992;4(2):125-33.
1992: K Müller; Freddy Karup Pedersen; A Wiik; Klaus Bendtzen
Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations.
Rheumatology international 1992;12(3):89-92.
1992: Karsten Buschard; C Pedersen; S V Hansen; I Hageman; K Aaen; Klaus Bendtzen
Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats.
Autoimmunity 1992;14(2):101-4.
1992: K Müller; Klaus Bendtzen
Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells.
Autoimmunity 1992;14(1):37-43.
1992: K S Kristensen; Klaus Bendtzen; Per Stahl Skov; M Pedersen; H Permin; Svend Norn
Modulation of IgE-mediated basophil histamine release by various cytokines.
Pneumonologia i alergologia polska 1992;60 Suppl 2():70-3.
1991: Morten B Hansen; M Svenson; Klaus Bendtzen
Human anti-interleukin 1 alpha antibodies.
Immunology letters 1991;30(1):133-9.
1991: Morten B Hansen; Morten Svenson; M Diamant; Klaus Bendtzen
Anti-interleukin-6 antibodies in normal human serum.
Scandinavian journal of immunology 1991;33(6):777-81.
1991: K Müller; M Diamant; Klaus Bendtzen
Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3.
Immunology letters 1991;28(2):115-20.
1991: P M Haahr; Bente Klarlund Pedersen; A Fomsgaard; N Tvede; M Diamant; K Klarlund; J Halkjaer-Kristensen; Klaus Bendtzen
Effect of physical exercise on in vitro production of interleukin 1, interleukin 6, tumour necrosis factor-alpha, interleukin 2 and interferon-gamma.
International journal of sports medicine 1991;12(2):223-7.
1991: M Svenson; L Kayser; Morten B Hansen; Ase Krogh Rasmussen; Klaus Bendtzen
Interleukin-1 receptors on human thyroid cells and on the rat thyroid cell line FRTL-5.
Cytokine 1991;3(2):125-30.
1991: M Pedersen; H Permin; C Bindslev-Jensen; Klaus Bendtzen; Svend Norn
Cytokine-induced histamine release from basophils of AIDS patients. Interaction between cytokines and specific IgE antibodies.
Allergy 1991;46(2):129-34.
1990: Morten Svenson; M Bagge Hansen; Klaus Bendtzen
Distribution and characterization of autoantibodies to interleukin 1 alpha in normal human sera.
Scandinavian journal of immunology 1990;32(6):695-701.
1990: Klaus Bendtzen; M Diamant; Viggo Faber
Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A.
Cytokine 1990;2(6):423-9.
1990: K Müller; P Oxholm; O H Sørensen; M Thymann; M Høier-Madsen; Klaus Bendtzen
Abnormal vitamin D3 metabolism in patients with primary Sjögren's syndrome.
Annals of the rheumatic diseases 1990;49(9):682-4.
1990: Lars Hviid; Thor G Theander; PH Jakobsen; Yousif Ali Abu-Zeid; N H Abdulhadi; B O Saeed; S Jepsen; Riad Bayoumi; Klaus Bendtzen; J B Jensen
Cell-mediated immune responses to soluble Plasmodium falciparum antigens in residents from an area of unstable malaria transmission in the Sudan.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1990;98(7):594-604.
1990: Klaus Bendtzen; Morten Svenson; Viggo Jønsson; E Hippe
Autoantibodies to cytokines--friends or foes?
Immunology today 1990;11(5):167-9.
1990: M Pedersen; H Permin; Klaus Bendtzen; Svend Norn
Cytokine-induced release of histamine from basophil leukocytes from AIDS patients.
Agents and actions 1990;30(1-2):294-6.
1990: Karsten Buschard; K Aaen; T Horn; J Van Damme; Klaus Bendtzen
Interleukin 6: a functional and structural in vitro modulator of beta-cells from islets of Langerhans.
Autoimmunity 1990;5(3):185-94.
1989: M Svenson; Klaus Bendtzen
Human urine deoxyribonuclease increases endogenous thymidine in the mouse thymocyte interleukin 1 assay: an artificial interleukin-1 inhibitor.
Cytokine 1989;1(1):52-5.
1989: A Fomsgaard; Morten Svenson; Klaus Bendtzen
Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections.
Scandinavian journal of immunology 1989;30(2):219-23.
1989: Morten Svenson; L K Poulsen; A Fomsgaard; Klaus Bendtzen
IgG autoantibodies against interleukin 1 alpha in sera of normal individuals.
Scandinavian journal of immunology 1989;29(4):489-92.
1989: Klaus Bendtzen
Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases.
Autoimmunity 1989;2(2):177-89.
1988: Klaus Bendtzen; Niels Morling; A Fomsgaard; Morten Svenson; B Jakobsen; Niels Odum; Arne Svejgaard
Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide.
Scandinavian journal of immunology 1988;28(5):599-606.
1988: Klaus Bendtzen
Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity.
Immunology letters 1988;19(3):183-91.
1988: P N Bouchelouche; Claus Reimert; Klaus Bendtzen
Effects of natural and recombinant interleukin-1 alpha and -beta on cytosolic free calcium in human and murine fibroblasts.
Leukemia 1988;2(10):691-6.
1988: Arsalan Kharazmi; Henrik Nielsen; Klaus Bendtzen
Modulation of human neutrophil and monocyte chemotaxis and superoxide responses by recombinant TNF-alpha and GM-CSF.
Immunobiology 1988;177(4-5):363-70.
1988: Thor G Theander; Arsalan Kharazmi; Bente Klarlund Pedersen; Lisa D Christensen; N Tvede; L K Poulsen; Niels Odum; M Svenson; Klaus Bendtzen
Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases.
Infection and immunity 1988;56(7):1673-7.
1988: Bente Klarlund Pedersen; N Tvede; F R Hansen; Vagn Andersen; T Bendix; G Bendixen; Klaus Bendtzen; Henrik Galbo; P M Haahr; K Klarlund
Modulation of natural killer cell activity in peripheral blood by physical exercise.
Scandinavian journal of immunology 1988;27(6):673-8.
1988: N Tvede; Lisa D Christensen; Niels Odum; Allan Wiik; Klaus Bendtzen
Interleukin 1-induced down-regulation of antibody binding to CD4 molecules on human lymphocytes.
Scandinavian journal of immunology 1988;27(6):679-84.
1988: M Svenson; Klaus Bendtzen
Inhibitor of interleukin 1 in normal human urine. Different effects on mouse thymocytes and on a murine T-cell line.
Scandinavian journal of immunology 1988;27(5):593-9.
1988: K Muller; M Svenson; Klaus Bendtzen
1 alpha,25-Dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro.
Immunology letters 1988;17(4):361-5.
1988: Arsalan Kharazmi; Henrik Nielsen; Klaus Bendtzen
Recombinant interleukin 1 alpha and beta prime human monocyte superoxide production but have no effect on chemotaxis and oxidative burst response of neutrophils.
Immunobiology 1988;177(1):32-9.
1988: A Fomsgaard; H Worsaae; Klaus Bendtzen
Detection of tumour necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay.
Scandinavian journal of immunology 1988;27(2):143-7.
1984: P Oxholm; K Winther; Klaus Bendtzen; G Bendixen
Lack of evidence for human lymphokines with thrombocyte aggregating activity. An in vitro study.
Allergy 1984;39(8):618-21.